Annual Accounts Receivable
N/A
31 December 2023
Summary:
Panbela Therapeutics annual accounts receivable is not available.PBLA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Panbela Therapeutics quarterly accounts receivable is not available.PBLA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBLA Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PBLA Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Panbela Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $12.00 K(-63.2%) |
| Mar 2015 | - | $32.60 K(-65.3%) |
| Dec 2014 | $94.00 K(+535.1%) | $94.00 K(+440.2%) |
| Sept 2014 | - | $17.40 K(+10.8%) |
| June 2014 | - | $15.70 K(-26.3%) |
| Mar 2014 | - | $21.30 K(+43.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $14.80 K(-80.4%) | $14.80 K(-24.9%) |
| Sept 2013 | - | $19.70 K(-88.4%) |
| June 2013 | - | $169.60 K(+106.3%) |
| Mar 2013 | - | $82.20 K(+8.9%) |
| Dec 2012 | $75.50 K(+77.2%) | $75.50 K |
| Dec 2011 | $42.60 K | - |
FAQ
- What is the all time high annual accounts receivable for Panbela Therapeutics?
- What is the all time high quarterly accounts receivable for Panbela Therapeutics?
What is the all time high annual accounts receivable for Panbela Therapeutics?
Panbela Therapeutics all-time high annual accounts receivable is $94.00 K
What is the all time high quarterly accounts receivable for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly accounts receivable is $169.60 K